Sequence polymorphisms in the apolipoprotein(a) gene and their associationwith lipoprotein(a) levels and myocardial infarction. The ECTIM Study

Citation
L. Brazier et al., Sequence polymorphisms in the apolipoprotein(a) gene and their associationwith lipoprotein(a) levels and myocardial infarction. The ECTIM Study, ATHEROSCLER, 144(2), 1999, pp. 323-333
Citations number
60
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
ATHEROSCLEROSIS
ISSN journal
00219150 → ACNP
Volume
144
Issue
2
Year of publication
1999
Pages
323 - 333
Database
ISI
SICI code
0021-9150(199906)144:2<323:SPITAG>2.0.ZU;2-P
Abstract
Lp(a) concentrations are largely determined by apo(a) isoform size, but sev eral studies have shown that apo(a) isoforms could not entirely explain the increase of Lp(a) levels observed in patients with coronary heart disease (CHD). Since up to 90% of the variance in Lp(a) levels has been suggested t o be attributable to the apo(a) locus, the hypothesis that polymorphisms of the apo(a) gene other than size could contribute to the increase of Lp(a) levels in CHD patients must be considered. This hypothesis was tested in th e ECTIM Study comparing 594 patients with myocardial infarction and 682 con trol subjects in Northern Ireland and France. In addition to apo(a) phenoty ping, five previously described polymorphisms of the apo(a) gene were genot yped: a (TTTTA)(n) repeat at position -1400 from the ATG, a G/A at -914, a C/T at -49, a G/A at -21 and a Met/Thr affecting amino acid 4168. As report ed earlier [Parra HJ, Evans AE, Cambou JP, Amouyel P, Bingham A, McMaster D , Schaffer P, Douste-Blazy P, Luc G, Richard JL, Ducimetiere P, Fruchart JC , Cambien F. A case-control study of lipoprotein particles in two populatio ns at contrasting risk for coronary heart disease. The ECTIM study. Arterio scler Thromb 1992;12:701-707], mean Lp(a) levels were higher in cases than in controls (20.7 vs 14.6 mg/dl in Belfast, 17.2 vs 8.9 mg/dl in France, P < 0.001 for case-control and population differences). In the present study, mean apo(a) isoform size differed significantly between cases and controls (25.7 vs 26.6 kr in Belfast, 25.9 vs 27.4 kr in France, P < 0.001 for case -control and P = 0.13 for population difference). After adjustment for apo( a) isoforms, Lp(a) levels remained significantly higher in cases than in co ntrols (difference, 4.6 mg/dl; P < 0.001). Genotype and allele frequencies did not differ significantly between cases and controls for any bf the five polymorphisms studied. The five polymorphisms were in strong linkage diseq uilibrium and had a combined heterozygosity of 0.83. In multivariate regres sion analysis adjusted for apo(a) isoforms, only the (TTTTA), polymorphism was significantly associated with Lp(a) levels; it explained 4.5% of Lp(a) variability in cases and 3.1% in controls. The Lp(a) case/control differenc e was not reduced after taking into account the (TTTTA)(n) effect. We concl ude that the increase of Lp(a) levels observed in MI cases, and which was n ot directly attributable to apo(a) size variation, was not related to the f ive polymorphisms of the apo(a) gene considered. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.